Pandemic wait is over: FDA begins transition to in-person meetings in March
It’s been almost three years since anyone has met with FDA staff in person at an FDA office. But that’s all about to change as the agency said yesterday that beginning Feb. 13, CDER and CBER will restart in-person, face-to-face industry meetings.
The big caveat: A face-to-face meeting with the FDA now includes virtual meetings with cameras on, as agreed to in the latest user fee deals between the industry and the FDA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
